PAULINE BURRALL: Open Payments
NPI 1881992568 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 35 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $19 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $170 |
| ABBVIE INC. | 11 | $161 |
| Lilly USA, LLC | 3 | $57 |
| Dexcom, Inc. | 3 | $57 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $29 |
| Astellas Pharma US Inc | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: Rybelsus, MOUNJARO, Dexcom G6 Transmitter, Ozempic, AVYCAZ, VRAYLAR, Wegovy, DALVANCE.
Industry payments across LA — which companies pay providers there.
